Skip to content

Medical-device intelligence

GQX: Antiserum, Cf, Varicella-Zoster

FDA product code GQX: Antiserum, Cf, Varicella-Zoster. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
GQX
FDA device name
Antiserum, Cf, Varicella-Zoster
Device class
2
Regulation number
866.3900
Medical specialty
Microbiology
Review panel
MI

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

11 clearance records and 2 recall records in the covered releases, across 11 source company names and 1 product codes. Dated history runs from May 20, 1977 to May 29, 2012.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
GQX · Antiserum, Cf, Varicella-Zoster112

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

13 matching records
Device / recordCompany in FDA recordSourceSource date
Trinity Biotech, Captia VZV IgG. Product code 2325600: 96 Tests; product code: 2325601: 480 tests. For in vitro diagnostic use. Intended for …Z-2445-2012 · GQXClark Laboratories, Inc. (dba,Trinity Biotech USA)RecallSep 24, 2012FDA classification date
VZV IgM ELISA 96 Well Kit, Catalog Number: VZ082M The products in question are all Enzyme Linked Immunosorbent Assay (ELISA) Test kits designed …Z-1004-2010 · GQXCalbiotech IncRecallMar 5, 2010FDA classification date
VARICELLA-ZOSTER VIRUS DIRECT IMMUNOFLUORESCENCE ASSAYK951799 · GQXLight Diagnostics510(k)Mar 20, 1996FDA decision date
VZV IGM TESTK911301 · GQXGull Laboratories, Inc.510(k)Jul 17, 1991FDA decision date
VIRGO(R) VZV-IGG ELISAK883427 · GQXElectro-Nucleonics, Inc.510(k)Mar 10, 1989FDA decision date
VZV TESTK875358 · GQXGull Laboratories, Inc.510(k)Mar 31, 1988FDA decision date
ENZYGNOST ANTI-VZV IGG TESTK863317 · GQXBehring Diagnostics, Inc.510(k)Apr 22, 1987FDA decision date
FIAX TEST KIT FOR VARICELLA ANTIBODY SEROLOGYK853540 · GQXIdt, A Division of Whittaker M.A. Bioproducts510(k)Feb 4, 1986FDA decision date
VARICELLA-ZOSTER-COMPLE FIX ANTIGEN AND NEG CONTROK852930 · GQXMicrobix Biosystems, Inc.510(k)Nov 12, 1985FDA decision date
GLB VARICELLA-ZOSTER VIRUS FLUORESCENTK842096 · GQXGreat Lakes Bioscience510(k)Jan 7, 1985FDA decision date
ORTHO VARICELLA-ZOSTER VIRUS IDENT.K841526 · GQXOrtho Diagnostic Systems, Inc.510(k)Jun 25, 1984FDA decision date
VARICELLA-ZOSTER FA LABELLED (8-321 RF)K770806 · GQXFlow Laboratories, Inc.510(k)May 20, 1977FDA decision date
VARICELLA-ZOSTER FA LABELED PRESERUMK770810 · GQXFlow Laboratories, Inc.510(k)May 20, 1977FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗